The purpose of this requirement is to procure services for globe and guard model implementation and monitoring. Brand-name drug prices in the united states are two to three times higher than prices in…
Active Awarded Last action
- Contract number
- 75FCMC26F0153
- Awardee
-
The Rand Corporation UEI YY46Q97AEZA8
- Awarding agency
-
Centers for Medicare and Medicaid Services
Department of Health and Human Services
- Obligated
- $3,888,079
Award facts
- Opportunity
-
- 75FCMC26R00520002 Solicitation number
- Contract value 14% obligated
-
- $3,888,079.09 Current, with exercised options
- $27,217,922.85 Potential, with all options
- Completion date 1% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Windsor Mill, Milford Mill, MD 21244, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Centers for Medicare and Medicaid Services issued a delivery order to The Rand Corporation on September 17, 2026, under the Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2) IDIQ for GLOBE and GUARD model implementation and monitoring services addressing brand-name drug pricing disparities. The order carries a ceiling value of $27,217,922.85 with cost-plus-fixed-fee pricing and an ultimate completion date of September 16, 2036.
RMADA 2 is an indefinite delivery contract supporting research, measurement, assessment, design, and analysis services across federal health and human services agencies. Place of performance is Windsor Mill and Milford Mill, Maryland. No set-aside applied to this order.
Description
The purpose of this requirement is to procure services for globe and guard model implementation and monitoring. Brand-name drug prices in the united states are two to three times higher than prices in comparable countries. To address this imbalance
Quick answers
Who was awarded contract 75FCMC26F0153?
75FCMC26F0153 was awarded to The Rand Corporation by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on September 17, 2026.
How much is contract 75FCMC26F0153 worth?
The government has obligated $3,888,079 on 75FCMC26F0153. Its potential value, with all options, is $27,217,923.
Is contract 75FCMC26F0153 an order under another contract?
Yes. 75FCMC26F0153 is a delivery order under 75FCMC19D0093, an indefinite delivery contract, on Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2).
Was contract 75FCMC26F0153 competed?
The extent of competition for 75FCMC26F0153 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award